Titan Pharmaceuticals, Inc.
TTNP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$803 | -$689 | -$563 | -$790 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $49 | $9 | -$304 | $284 |
| Other Non-Cash | $0 | $0 | $0 | $0 |
| Operating Cash Flow | -$754 | -$680 | -$867 | -$506 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$5 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $1,600 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$89 | -$62 | -$19 | -$62 |
| Financing Cash Flow | -$89 | $1,538 | -$19 | -$62 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$848 | $858 | -$886 | -$568 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,803 | $1,945 | $2,831 | $3,399 |
| End Cash | $1,955 | $2,803 | $1,945 | $2,831 |
| Free Cash Flow | -$759 | -$680 | -$867 | -$506 |